期刊文献+

重症监护病房临床分离病原菌分布及耐药性分析 被引量:2

Analysis of the distribution and antibiotic resistance of pathogenic bacterial isolates from clinical specimens in intensive care unit
原文传递
导出
摘要 目的 及时了解和动态掌握重症监护病房(ICU)病原菌分布及耐药趋势,指导临床合理使用抗菌药物.方法 对我院ICU 2007年-2009年所分离的病原菌的菌群分布及耐药性进行回顾性分析.结果 共分离出病原菌705株.其中革兰阴性菌占57.16%;革兰阳性菌占30.21%,真菌占12.62%.鲍曼不动杆菌和铜绿假单胞菌呈多重耐药.结论 非发酵菌已成为ICU感染的最常见病原菌,对常用抗生素耐药严重,应加强耐药监测,合理使用抗生素对有效控制ICU感染十分重要. Objective To acquire the timely knowledge and dynamic information of the distribution of pathogenic bacteria and their trend in antibiotic resistance in intensive care unit (ICU) , and provide clinical guidance on rational use of antibiotics. Methods A retrospective analysis was conducted on the distribution of bacterial flora and drug resistance of microbial isolates from 2007 to 2009 in our ICU. Results A total of 705 strains of pathogenic bacteria were isolated: Gram -negative bacilli were 57.16 % ; Gram -positive cocci accounted for 30.21% and fungi comprised 12.62 % of the bacteria. Non - zymophytes were muhidrug resistant. Conclusion Acinetobacter baumannii and Pseudomonas aeruginosa are the most frequent pathogenic bacteria and are strongly resistant to common antibiotics. Drug resistance surveillance should be emphasized and rational use of antibiotics is of great importance to the effective control of infections in ICU.
出处 《徐州医学院学报》 CAS 2011年第4期277-279,共3页 Acta Academiae Medicinae Xuzhou
关键词 重症监护病房(ICU) 病原菌 耐药性 intensive care unit (ICU) : pathogenic bacteria drug resistance
  • 相关文献

参考文献6

二级参考文献26

  • 1张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 2李红玉,潘昆贻,伍锡泉,钟日辉.广州地区1999~2003年鲍曼不动杆菌的耐药性调查[J].热带医学杂志,2005,5(2):203-204. 被引量:10
  • 3巫胡兰,邹英,张杰,张晓兵.62例鲍曼不动杆菌的感染分布和耐药性分析[J].重庆医学,2006,35(24):2211-2212. 被引量:8
  • 4Kaul R, Burr JA, Cork L, et al. Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factor and attributable mortality[J].infect Dis, 1996, 174(6): 1279-1287.
  • 5Ruiz J, Navia MM, CasalsC, et al. Integron-mediated antibiofiic multiresistance in Acinetobacter baumannii clinical isolation from Spain[J]. Clin Microbiol Infect, 200, 9(9): 907-911.
  • 6Vial J, Ruiz J, Goni P, et al. Mutation in the gyrAgene of quinolone-resistantclinical isolates of Acinetobacter baumannii [J].Antimicrob Agent Chemother, 1995, 39(5): 1201-1203.
  • 7Shibata N, Doi Y, Yamane K, et al. PCR typing of genetic determination for metallo-beta-lactanases and integrases carried by gram-negrative bacteria isolated in Japan[J]. J Clin microbiol, 2003,41(2): 5407-5413.
  • 8Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin resistant Staphylococcus aureus isolated from a patient in Pennsylvania[J].Antimicrob Agents Chemother, 2004, 48(1): 275-280.
  • 9Denis O, Nonhoff C, Byi B, et al. Emergence of Vancomycin intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features[J]. J Antimicrob Chemother, 2002, 50(3): 383-391.
  • 10Afzal-Shah M,Livermore DM.Worldwide emergence of carbapenem-resistant Acinetobacter spp[J].J Antimicrob Chemother,1998,41:576-577.

共引文献79

同被引文献19

  • 1张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 2Paul M, Carmeli Y, Durante-Mangoni E, et al. Combination therapy for carbapenem-resistant Gram-negative bacteria [ J ]. J Antimicrob Che- mother,2014,69 ( 9 ) :2305-2309.
  • 3Stock I. Infectious diseases caused by carbapenemase-producing Enter- obacteriaceae--a particular challenge for antibacterial therapy [ J ]. Med Monatsschr Pharm,2014,37 (5) : 162-172.
  • 4Ojdana D, Sacha P, Olszafiska D, et al. First Report of Klebsiella pneu- moniae-Carbapenemase-3-Pmducing Escherichia coli ST479 in Poland [ J 1. Biomed Research International ,2014,2015 (41). DO1:10.1155/ 2015/256028.
  • 5Biberg CA, Rodrigues AC, do Camlo SF, et al. KPC-2-producing Kleb- siella pneumoniae in a hospital in the Midwest region of Brazil [ J ]. Braz J Mierobiol,2015,46(2) :501-504.
  • 6Morrill H J, Pogue JM, Kaye KS, et al. Treatment Options for Carbapen- era-Resistant Enterobacteriaceae Infections [ J ]. Open Forum Infect Dis, 2015,2 ( 2 ). DOI : 10.1093/otld/ofv050.
  • 7Clinieal and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing [ S ]. M100-S23, Wayne, PA: CLSI,2013.
  • 8Kim JW, Chung J, Choi SH, et al. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobi- als without de-escalation for patients with hospital-acquired pneumonia in a medical ICU :a randomized clinical trial[ J ]. Crit Care ,2012,16 : R28.
  • 9Mathers A J, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multi-drug-resistant Entembacteriaceae [ J ]. Clin Microbiol Rev, 2015,28 (3) :565-591.
  • 10Biberg CA, Rodrigues AC, do Carmo, et al. SFKPC-2-producing Kleb- siella pneumoniae in a hospital in the Midwest region of Brazil [ J ]. Braz J Microbiol,2015,46(2) :501-504.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部